High-dose cytosine arabinoside in the treatment of refractory acute nonlymphocytic leukemia in adults: Results of two six-day regimens
暂无分享,去创建一个
H. Lazarus | R. Herzig | S. Wolff | G. Herzig | G. Phillips
[1] U. Roessmann,et al. Central nervous system toxicity of high‐dose systemic cytosine arabinoside , 1981, Cancer.
[2] D. Rosenthal,et al. Treatment of acute myelogenous leukemia in children and adults. , 1980, The New England journal of medicine.
[3] C. Bloomfield,et al. Intensive five‐drug combination chemotherapy for adult acute non‐lymphocytic leukemia , 1980, Cancer.
[4] J. Bertino,et al. High dose cytosine arabinoside (HDARAC) in refractory acute leukemia , 1979, Cancer.
[5] E. Henderson,et al. Treatment of acute nonlymphocytic leukemia: use of anthracycline-cytosine arabinoside induction therapy and comparison of two maintenance regimens. , 1979, Blood.
[6] R. Gale,et al. HIGH REMISSION-INDUCTION RATE IN ACUTE MYELOID LEUKÆMIA , 1977, The Lancet.
[7] C. Coltman,et al. Progress in the treatment of adults with acute leukemia: review of regimens containing cytarabine studied by the Southwest Oncology Group. , 1976, Archives of internal medicine.
[8] C. Spurr,et al. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia , 1975, Cancer.
[9] E. Gehan,et al. Chemotherapy of acute leukemia. Comparison of cytarabine alone and in combination with vincristine, prednisone, and cyclophosphamide. , 1974, Archives of internal medicine.
[10] E. Gehan,et al. Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response. , 1974, Archives of internal medicine.
[11] G. Bodey,et al. Prolonged infusion of arabinosyl cytosine in childhood leukemia , 1970, Cancer.
[12] M. Boiron,et al. Daunorubicin in the treatment of acute myelocytic leukaemia. , 1969, Lancet.
[13] C. Spurr,et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. , 1968, Blood.